自 1997年 3月～ 2 0 0 1年 3月间 ,我们采用术中膀胱粘膜下浸润注射羟基喜树碱以及术后灌注羟基喜树碱预防膀胱癌术后复发的方法共 3 7例。兹将临床观察结果报道如下。临床资料一、一般资料 :本组 3 7例 ,男 2 7例 ,女 10例 ,年龄 3 9～ 72岁 ,平均年龄 5 2 .7岁 ,所有病例均 From March 1997 to March 2001, we used intraoperative submucosal infiltration of hydroxycamptothecine and intraperitoneal infusion of hydroxycamptothecin to prevent postoperative recurrence of bladder cancer, a total of 37 cases. The clinical observations are reported below. Clinical data First, the general information: The group of 37 cases, 27 males and 10 females, aged 39 to 72 years, mean age 52.7 years old, all cases were